BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37175546)

  • 1. The Role of NQO1 in Ovarian Cancer.
    Tossetta G; Fantone S; Goteri G; Giannubilo SR; Ciavattini A; Marzioni D
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
    Joseph P; Jaiswal AK
    Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector.
    Dinkova-Kostova AT; Talalay P
    Arch Biochem Biophys; 2010 Sep; 501(1):116-23. PubMed ID: 20361926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) modulates the differentiation of Th17 cells by regulating ROS levels.
    Nishida-Tamehiro K; Kimura A; Tsubata T; Takahashi S; Suzuki H
    PLoS One; 2022; 17(7):e0272090. PubMed ID: 35905076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants.
    Rashid MH; Babu D; Siraki AG
    Chem Biol Interact; 2021 Aug; 345():109574. PubMed ID: 34228969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of genes encoding NAD(P)H:quinone oxidoreductases.
    Jaiswal AK
    Free Radic Biol Med; 2000 Aug; 29(3-4):254-62. PubMed ID: 11035254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
    Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
    Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer.
    Madajewski B; Boatman MA; Martinez I; Carter JH; Bey EA
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
    Glorieux C; Sandoval JM; Dejeans N; Ameye G; Poirel HA; Verrax J; Calderon PB
    Life Sci; 2016 Jan; 145():57-65. PubMed ID: 26687450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD(P)H:Quinone Acceptor Oxidoreductase 1 (NQO1) Activatable Salicylamide H
    Roy NJ; Save SN; Sharma VK; Abraham B; Kuttanamkuzhi A; Sharma S; Lahiri M; Talukdar P
    Chemistry; 2023 Sep; 29(51):e202301412. PubMed ID: 37345998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
    Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
    Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.
    Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C
    BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway.
    Preethi S; Arthiga K; Patil AB; Spandana A; Jain V
    Mol Biol Rep; 2022 Sep; 49(9):8907-8924. PubMed ID: 35347544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD(P)H: quinone oxidoreductase 1 attenuates oxidative stress and apoptosis by regulating Sirt1 in diabetic nephropathy.
    Qiu D; Song S; Wang Y; Bian Y; Wu M; Wu H; Shi Y; Duan H
    J Transl Med; 2022 Jan; 20(1):44. PubMed ID: 35090502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.
    Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D
    J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of RH1 and related aziridinylbenzoquinones: involvement of activation by NAD(P)H:quinone oxidoreductase (NQO1) and oxidative stress.
    Nemeikaite-Ceniene A; Sarlauskas J; Anusevicius Z; Nivinskas H; Cenas N
    Arch Biochem Biophys; 2003 Aug; 416(1):110-8. PubMed ID: 12859987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4.
    Shaw PM; Reiss A; Adesnik M; Nebert DW; Schembri J; Jaiswal AK
    Eur J Biochem; 1991 Jan; 195(1):171-6. PubMed ID: 1899380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
    Colucci MA; Moody CJ; Couch GD
    Org Biomol Chem; 2008 Feb; 6(4):637-56. PubMed ID: 18264564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma.
    Shimokawa M; Yoshizumi T; Itoh S; Iseda N; Sakata K; Yugawa K; Toshima T; Harada N; Ikegami T; Mori M
    Cancer Sci; 2020 Apr; 111(4):1228-1240. PubMed ID: 31968140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.